CRESTCHEM LTD.

Crestchem Ltd announced the revised outcome of its board meeting held on May 29, 2026. The board approved the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. Additionally, they noted the formation of a subsidiary, Oleo Biosciences Private Limited, incorporated on March 31, 2026, which has not commenced commercial operations. A final dividend of ₹1.50 per equity share (15%) for FY 2025-26 was recommended, subject to shareholder approval. The board also approved the reappointment and remuneration of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms. Investment up to ₹2.25 Crores in the subsidiary was also approved.

Crestchem Ltd announced the outcome of its Board Meeting held on July 4, 2026. The board has fixed August 6, 2026, as the date for the 34th Annual General Meeting (AGM). Key approvals include the notice for the AGM, the Board of Directors' report, the Corporate Governance report, and the Management Discussion and Analysis Report. Additionally, the company approved opening a dividend account for the financial year 2025-26 and fixed the book closure and record date for dividend payment. The board also decided to arrange a Video Conference Meeting/OVAM with CDSL. The meeting concluded at 2:30 PM.

Crestchem Ltd has announced the closure of its trading window for designated persons, directors, and key management personnel. The window will be closed from July 01, 2026, until 48 hours after the announcement of the unaudited financial results for the first quarter ended June 30, 2026. This measure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct, aimed at preventing insider trading during the period leading up to and immediately following the financial results disclosure.

Crestchem Ltd has announced that its Board of Directors will convene on July 4, 2026, to discuss and approve key agenda items. The primary focus will be fixing the date for the 34th Annual General Meeting (AGM) and approving its notice. Other significant matters include the approval of the Board of Directors report, Corporate Governance Report, and the Management Discussion & Analysis Report. The board will also decide on opening a dividend account with HDFC Bank, fixing the book closure and record date for the FY2025-26 dividend, and approving the calendar of events for the AGM. The meeting is scheduled for 12:15 PM.

Crestchem Ltd. has disclosed a sale of 14,600 equity shares by Ms. Sonal Dushyant Patel, a member of the promoter group and sister of promoter Dipak N. Patel. The transaction, executed through open market sales on June 23, 2026, involved 14,600 shares, reducing her holding to 5,295 shares. The total value of the sale amounted to ₹12,96,822. This disclosure is made pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

Sonal Dushyant Patel, a member of the promoter group and sister of a promoter, has disclosed the sale of 14,600 equity shares in Crestchem Limited. The transaction, conducted through open market sales, resulted in her shareholding decreasing from 14,600 shares to 7,795 shares. The sale occurred on June 22, 2026, and was intimated to the company on June 23, 2026. The total value of the disposed shares was ₹947,379. This disclosure is made in accordance with SEBI (Prohibition of Insider Trading) Regulations, 2015.

Crestchem Ltd's Board of Directors approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26, subject to shareholder approval at the upcoming 34th Annual General Meeting. Additionally, the company announced the formation of a new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, incorporated on March 31, 2026, and approved an investment of up to ₹2.25 Crores in it. The board also approved the reappointments and remunerations of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms.

Crestchem Ltd's Board of Directors approved the Audited Standalone & Consolidated Financial Results for the quarter and financial year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share (15%) for FY2025-26, subject to shareholder approval at the upcoming 34th Annual General Meeting. The company also noted the formation of a new subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, and approved an investment of up to ₹2.25 Crores in it. Furthermore, the reappointments and remuneration of Mr. Dipak Narendraprasad Patel, Mrs. Parul Dipak Patel, and Mrs. Tansi Nirmit Patel for five-year terms were approved.

Crestchem Ltd's board has approved and adopted the audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. The board recommended a final dividend of ₹1.50 per equity share (15%) for the financial year 2025-26, subject to shareholder approval. Additionally, the board approved the formation of a subsidiary, OLEO BIOSCIENCES PRIVATE LIMITED, and various reappointment and remuneration approvals for key personnel.

Crestchem Ltd has informed the BSE that the Board of Directors meeting, initially scheduled for May 26, 2026, has been adjourned due to the lack of a quorum. The meeting is now rescheduled for Friday, May 29, 2026, at 12:15 PM. The agenda for the meeting remains the same as per the notice issued on May 18, 2026. This information is for the BSE Stock Exchange and the public at large.